SEC Form 4 · accession 0000874015-19-000051
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
B Lynne Parshall
Director
Period of report
Mar 12, 2019
Accepted (ET)
Mar 14, 2019 · 6:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 12, 2019 | M | 8,334 | $39.87 | A | 61,011 | D | |
| Common StockF1 | Mar 12, 2019 | S | 8,334 | $75.00 | D | 52,677 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $39.87 | Mar 12, 2019 | M | 8,334 | A | Jan 2, 2018 | Jan 1, 2021 | Common Stock | 8,334 | 57,500 | D |
Explanation of responses
- F1Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 8/8/2017.